Cellectis Presents Clinical Data on AMELI-01 and Preclinical

NEW YORK, May 17, 2023 -- Cellectis , a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today presents clinical data... | June 12, 2023

Related Keywords

New York , United States , North Carolina , Raleigh , France , Paris , France General , American , Daniel Lee , Beatriz Aranda Orgilles , Ashleyr Robinson , Mark Frattini , Arthur Stril , Pascalyne Wilson , Team Leader , Eu Press , American Society Of Hematology , Securities Exchange Commission , American Society Of Gene , Nasdaq , Cellectis The Company Euronext Growth , Clinical Sciences , Euronext Growth , Clinical Data , Dose Regimen , Chief Medical Officer , Phasei Trial , Adult Patients , Acute Myeloid Leukemia , Production Advances , Targeting Hematologic , Solid Tumor , Abstract Number , Multiplex Engineering , Superior Generation , Board Number , Nasdaq Global Market , Private Securities Litigation Reform Act , Annual Report , Exchange Commission , Chief Business Officer , Sci Advisors ,